Ambrx Biopharma Inc.
Ambrx Biopharma Inc. (AMAM) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 27 transactions totaling $123.9M, demonstrating a bullish sentiment with $122.6M in net insider flow. The most recent transaction on Mar 7, 2024 involved a transaction of 22,936 shares valued at $0.
AMAM Insider Activity Summary
Who Is Buying AMAM Stock?
No significant insider buying has been recorded for AMAM in the recent period.
Who Is Selling AMAM Stock?
No significant insider selling has been recorded for AMAM in the recent period.
Is Ambrx Biopharma Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AMAM is bullish with an Insider Alignment Score of 100/100 and a net flow of $122.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AMAM Frequently Asked Questions
Understanding AMAM Insider Activity
Insider trading at Ambrx Biopharma Inc. (AMAM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading AMAM stock, having executed 27 transactions in the past 90 days. The most active insider is Bihua Chen (Executive), who has made 3 transactions totaling $59.0M.
Related Tools
Track Ambrx Biopharma Inc. Insider Activity
Get notified when executives and directors at AMAM file new Form 4 transactions